EM
BIS icon

Emancipation Management’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Emancipation Management’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,625
Closed -$643K – 49
2015
Q4 		$643K Buy
+2,625
New +$675K 0.6% 26

Other funds holding BIS

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Emancipation Management's BIS Position: Q1 2016 in Review

Emancipation Management sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q1 2016, closing a stake of 2,625 shares — an estimated $643K sold.

Emancipation Management first reported a position in BIS in Q4 2015 and held it in 1 quarter. The position peaked at $643K in Q4 2015. 14 funds tracked by Wall St. Rank hold BIS as of Q1 2016.

  • Emancipation Management reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q1 2016 after selling out during the quarter.
  • Emancipation Management sold 2,625 ProShares UltraShort NASDAQ Biotechnology shares in Q1 2016, an estimated $643K.
  • Emancipation Management first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q4 2015 and held it in 1 quarter.
  • Emancipation Management's ProShares UltraShort NASDAQ Biotechnology position peaked at $643K in Q4 2015.
  • 14 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q1 2016.

Based on Emancipation Management's 13F filing for Q1 2016, filed 12 May 2016.